An Analysis of the Altria-Juul Labs Deal: Antitrust and Population Health Implications

David T Levy, Luz María Sánchez-Romero, Clifford E Douglas, David T Sweanor

Open source

DOI
10.1093/joclec/nhaa033
Published
2021-01-23
Container
Journal of Competition Law & Economics
Publisher
Oxford University Press (OUP)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/joclec/nhaa033,
  title = {An Analysis of the Altria-Juul Labs Deal: Antitrust and Population Health Implications},
  author = {David T Levy and Luz María Sánchez-Romero and Clifford E Douglas and David T Sweanor},
  year = {2021},
  journal = {Journal of Competition Law \& Economics},
  doi = {10.1093/joclec/nhaa033},
  url = {https://doi.org/10.1093/joclec/nhaa033}
}

RIS

TY  - JOUR
TI  - An Analysis of the Altria-Juul Labs Deal: Antitrust and Population Health Implications
AU  - David T Levy
AU  - Luz María Sánchez-Romero
AU  - Clifford E Douglas
AU  - David T Sweanor
PY  - 2021
JO  - Journal of Competition Law & Economics
DO  - 10.1093/joclec/nhaa033
UR  - https://doi.org/10.1093/joclec/nhaa033
ER  - 

APA

Levy, D. T., Sánchez-Romero, L. M., Douglas, C. E., & Sweanor, D. T. (2021). An Analysis of the Altria-Juul Labs Deal: Antitrust and Population Health Implications. Journal of Competition Law & Economics. https://doi.org/10.1093/joclec/nhaa033

Source records